High-dose steroids in childhood acute idiopathic thrombocytopenia purpura
- PMID: 3526937
High-dose steroids in childhood acute idiopathic thrombocytopenia purpura
Abstract
Nine newly diagnosed, previously untreated children (mean age: 4.2 years, range: 1-9 years) with severe acute idiopathic thrombocytopenia purpura (mean platelet count: 5.8 X 10(9)/L, range: 1-12 X 10(9)/L) were treated with high-dose steroids (prednisone 4-8 mg/kg/day). Steroid dose was based on platelet count at presentation: Group I (platelets less than 5 X 10(9)/L) was started on 8 mg/kg/day; Group II (platelets 5-15 X 10(9)/L) received 6 mg/kg/day. All patients had serologic and histologic evidence of acute idiopathic thrombocytopenia purpura. On this protocol, it took a mean number of 1.9 days (1-3 days) to reach a platelet count of at least 20 X 10(9)/L and 9.2 days (3-26 days) to reach a normal platelet count. No significant toxicity was observed except for weight gain ranging from 3-10% and mild behavioral problems. Both groups were on high-dose steroids (4-8 mg/kg/day) for 7.3 +/- 2.1 days. Only one patient had a brief relapse to a platelet count of 18 X 10(9)/L while on therapy (day 14), but responded promptly to an increase in prednisone dose. Presently, all nine patients are in remission and have not required maintenance medication.
Similar articles
-
[Treatment of acute immune thrombocytopenic purpura in children--intravenous immunoglobulin or treatment with corticosteroids?].Pediatr Pol. 1996 Jan;71(1):25-9. Pediatr Pol. 1996. PMID: 8966063 Polish.
-
A comparative study of initial use of intravenous immunoglobulin and prednisolone treatments in childhood idiopathic thrombocytopenic purpur.Acta Paediatr Taiwan. 2006 Sep-Oct;47(5):226-31. Acta Paediatr Taiwan. 2006. PMID: 17352309
-
A cooperative clinical trial of high-dose immunoglobulin therapy in 177 cases of idiopathic thrombocytopenic purpura.Thromb Haemost. 1984 Apr 30;51(2):182-5. Thromb Haemost. 1984. PMID: 6539957
-
Childhood acute immune thrombocytopenic purpura: 20 years later.Semin Thromb Hemost. 2003 Dec;29(6):605-17. doi: 10.1055/s-2004-815628. Semin Thromb Hemost. 2003. PMID: 14719177 Review.
-
Successful intravenous immune globulin therapy for human immunodeficiency virus-associated thrombocytopenia.Arch Intern Med. 1988 Mar;148(3):695-7. Arch Intern Med. 1988. PMID: 3277573 Review.
Cited by
-
Systematic review of the toxicity of short-course oral corticosteroids in children.Arch Dis Child. 2016 Apr;101(4):365-70. doi: 10.1136/archdischild-2015-309522. Epub 2016 Jan 14. Arch Dis Child. 2016. PMID: 26768830 Free PMC article.
-
The nontreatment of childhood idiopathic thrombocytopenic purpura.Eur J Pediatr. 1987 Mar;146(2):107-12. doi: 10.1007/BF02343213. Eur J Pediatr. 1987. PMID: 3552690 Review.
-
Effects of Delayed Antibiotic Therapy on Outcomes in Children with Streptococcus pneumoniae Sepsis.Antimicrob Agents Chemother. 2019 Aug 23;63(9):e00623-19. doi: 10.1128/AAC.00623-19. Print 2019 Sep. Antimicrob Agents Chemother. 2019. PMID: 31262764 Free PMC article.
-
Management of immune thrombocytopenic purpura: an update.Ochsner J. 2012 Fall;12(3):221-7. Ochsner J. 2012. PMID: 23049459 Free PMC article.
-
High dose Intravenous Anti-D Immune Globulin is More Effective and Safe in Indian Paediatric Patients of Immune Thrombocytopenic Purpura.J Clin Diagn Res. 2016 Dec;10(12):FC12-FC15. doi: 10.7860/JCDR/2016/20347.8976. Epub 2016 Dec 1. J Clin Diagn Res. 2016. PMID: 28208873 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical